Mitochondrial Genome Sequencing
MLPA (Multiplex Ligation-dependent Probe Amplification) is a diagnostic technique used for the molecular analysis of copy number variations (CNVs) in the genome. This assay makes the use of probes specific to selective genes in order to reliably diagnose genetic disorders resulting from deletions or duplications in said genes.
Tests Offered
DMD By MLPA
- Duchene Muscular Dystrophy
TAT: 18 Working Days
SMA By MLPA
- Spinal Muscular Atrophy
TAT: 18 Working Days
PMP22 By MLPA
- Charcot-Marie-Tooth (CMT) Hereditary Neuropathy
TAT: 25 Working Days
FBN1 By MLPA
- Marfan Syndrome
TAT: 25 Working Days
Atypical HUS ((CFHR3/CFHR1/ CFH/ CFH2/ CFH4) By MLPA
- Atypical Hemolytic Uremic Syndrome
TAT: 18 Working Days
BRCA1/2 By MLPA
- Hereditary Breast and Ovarian Cancer (HBOC)
TAT: 25 Working Days
Note:
- *MLPA for other genes can be performed on request. Please contact info@ncgmglobal.com.